Javascript must be enabled to continue!
Medicaid Expansion and Mortality Reduction in Women with Ovarian Cancer: A Population-Based Cohort Study
View through CrossRef
Objective: To evaluate the impact of Medicaid expansion under the
Affordable Care Act (ACA) on overall mortality among women diagnosed
with ovarian cancer and to assess whether the benefits varied by
race/ethnicity and neighborhood income level. Design: Retrospective,
population-based cohort study using a difference-in-differences approach
with Cox proportional hazards modeling. Setting: Statewide cancer
registry data from the United States, 2005 to 2022. Population: A total
of 88,024 women aged 40–64 years diagnosed with primary ovarian cancer.
Methods: States were categorized as early Medicaid expansion
(implemented by 2014) or non-expansion. Adjusted hazard differences were
estimated to assess the association between Medicaid expansion and
overall mortality. Subgroup and three-way interaction analyses examined
disparities by race/ethnicity and ZIP code–level income. Main Outcome
Measures: Overall mortality measured as adjusted differences in log
hazard ratios pre- and post-expansion. Results: We analyzed a cohort of
88,024 women aged 40–64 years diagnosed with ovarian cancer between
2005 and 2022 Of these, 44,608 (50.7%) were diagnosed before Medicaid
expansion and 43,416 (49.3%) after. In expansion states, the proportion
of Medicaid beneficiaries increased from 10.2% pre-expansion to 18.0%
post-expansion. In contrast, non-expansion states showed only a modest
increase (8.2% to 9.0%). Expansion states also saw a sharp decline in
the uninsured rate, dropping from 6.3% to 2.5%, while non-expansion
states experienced only a minor change (11.2% to 10.2%). Medicaid
expansion was associated with a 38.0% reduction in overall mortality
compared to non-expansion states [DID]: -0.380, 95% CI: –0.647 to
–0.114; p=0.005).Conclusions: Medicaid expansion was associated with
increased Medicaid coverage, reduced uninsured rates, and a significant
reduction in overall mortality among women with ovarian cancer in the
United States.
Title: Medicaid Expansion and Mortality Reduction in Women with Ovarian Cancer: A Population-Based Cohort Study
Description:
Objective: To evaluate the impact of Medicaid expansion under the
Affordable Care Act (ACA) on overall mortality among women diagnosed
with ovarian cancer and to assess whether the benefits varied by
race/ethnicity and neighborhood income level.
Design: Retrospective,
population-based cohort study using a difference-in-differences approach
with Cox proportional hazards modeling.
Setting: Statewide cancer
registry data from the United States, 2005 to 2022.
Population: A total
of 88,024 women aged 40–64 years diagnosed with primary ovarian cancer.
Methods: States were categorized as early Medicaid expansion
(implemented by 2014) or non-expansion.
Adjusted hazard differences were
estimated to assess the association between Medicaid expansion and
overall mortality.
Subgroup and three-way interaction analyses examined
disparities by race/ethnicity and ZIP code–level income.
Main Outcome
Measures: Overall mortality measured as adjusted differences in log
hazard ratios pre- and post-expansion.
Results: We analyzed a cohort of
88,024 women aged 40–64 years diagnosed with ovarian cancer between
2005 and 2022 Of these, 44,608 (50.
7%) were diagnosed before Medicaid
expansion and 43,416 (49.
3%) after.
In expansion states, the proportion
of Medicaid beneficiaries increased from 10.
2% pre-expansion to 18.
0%
post-expansion.
In contrast, non-expansion states showed only a modest
increase (8.
2% to 9.
0%).
Expansion states also saw a sharp decline in
the uninsured rate, dropping from 6.
3% to 2.
5%, while non-expansion
states experienced only a minor change (11.
2% to 10.
2%).
Medicaid
expansion was associated with a 38.
0% reduction in overall mortality
compared to non-expansion states [DID]: -0.
380, 95% CI: –0.
647 to
–0.
114; p=0.
005).
Conclusions: Medicaid expansion was associated with
increased Medicaid coverage, reduced uninsured rates, and a significant
reduction in overall mortality among women with ovarian cancer in the
United States.
Related Results
Prescription opioid availability and opioid overdose‐related mortality rates in Medicaid expansion and non‐expansion states
Prescription opioid availability and opioid overdose‐related mortality rates in Medicaid expansion and non‐expansion states
AbstractAimsTo determine whether, in the United States, higher opioid overdose‐related mortality rates (OOMR) in Affordable Care Act (ACA) Medicaid expansion states relative to mor...
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Safety and Efficacy of Atezolizumab in Ovarian Cancer
Abstract
Introduction
Although the efficacy of PD-L1 blockade has been evaluated in analyses that combine pharmacologically distinct antibodies, the specific efficacy and safety of...
Medicaid Expansion and Severe Maternal Morbidity
Medicaid Expansion and Severe Maternal Morbidity
OBJECTIVE:
To evaluate whether there is an association between state-level Medicaid expansion and severe maternal morbidity (SMM) among Medicaid enrollees who d...
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract IA31: Molecular epidemiology of ovarian cancer
Abstract
Epithelial ovarian cancer (EOC) accounts for 5% of all cancer deaths and is the fifth leading cause of cancer death in women in the United States. While the...
Abstract 2208: Clinicopathological and genetic study of ovarian cancer in Algerian women: First report
Abstract 2208: Clinicopathological and genetic study of ovarian cancer in Algerian women: First report
Abstract
Background: Ovarian cancer represents the fourth most common cause of mortality among Algerian women. Of all gynecological malignancies, ovarian cancer caus...
Abstract B81: Changing fertility factors affecting breast cancer in the Bahamas
Abstract B81: Changing fertility factors affecting breast cancer in the Bahamas
Abstract
Introduction: There are many factors that affect breast and ovarian cancer incidence. Genetics, obesity, parity, age at menarche, age at first pregnancy, an...
Abstract B8: Molecular subtyping of epithelial ovarian cancer reveals connections to intrinsic breast cancer subtypes
Abstract B8: Molecular subtyping of epithelial ovarian cancer reveals connections to intrinsic breast cancer subtypes
Abstract
Aim: Epithelial ovarian cancer is one of the most lethal female cancers. It is a heterogeneous group of neoplasms and the different histologic subtypes are ...
Women in Australian Politics: Maintaining the Rage against the Political Machine
Women in Australian Politics: Maintaining the Rage against the Political Machine
Women in federal politics are under-represented today and always have been. At no time in the history of the federal parliament have women achieved equal representation with men. T...

